Results 81 to 90 of about 273,364 (223)
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
New England Journal of Medicine, 2015 BACKGROUND The combination of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor, and the NS5B inhibitor sofosbuvir has shown efficacy in patients with HCV monoinfection.
D. Wyles +26 more
semanticscholar +1 more source
The Hubble Catalog of Variables [PDF]
, 2017 The Hubble Catalog of Variables (HCV) is a 3 year ESA funded project that aims to develop a set of algorithms to identify variables among the sources included in the Hubble Source Catalog (HSC) and produce the HCV. We will process all HSC sources with more than a predefined number of measurements in a single filter/instrument combination and compute a ...
arxiv +1 more source
National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.
Journal of the American Society of Nephrology, 2019 BACKGROUND Recent pilot trials have demonstrated the safety of transplanting HCV-viremic kidneys into HCV-seronegative recipients. However, it remains unclear if allograft function is impacted by donor HCV-viremia or recipient HCV-serostatus.
V. Potluri +13 more
semanticscholar +1 more source
Cryoglobulinemia and hepatitis C virus
Журнал инфектологии, 2014 The review presents recent data on cryoglobulinemiaassociated with a hepatitis C virus: prevalence, pathogenesis, clinical manifestations, laboratory diagnostics, approaches to therapy.
N. V. Dunaeva, E. V. Esaulenko
doaj +1 more source
Gastroenterology, 2016 BACKGROUND & AIMS We evaluated the effects of baseline hepatitis C virus (HCV) NS5A, NS5B, and NS3 resistance-associated substitutions (RASs) on response to the combination of ledipasvir and sofosbuvir, with or without ribavirin, in patients with HCV ...
C. Sarrazin +15 more
semanticscholar +1 more source
A Bayesian Evidence Synthesis Approach to Estimate Disease Prevalence in Hard-To-Reach Populations: Hepatitis C in New York City [PDF]
arXiv, 2018 Existing methods to estimate the prevalence of chronic hepatitis C (HCV) in New York City (NYC) are limited in scope and fail to assess hard-to-reach subpopulations with highest risk such as injecting drug users (IDUs). To address these limitations, we employ a Bayesian multi-parameter evidence synthesis model to systematically combine multiple sources
arxiv
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.
New England Journal of Medicine, 2014 BACKGROUND The interferon-free regimen of ABT-450 with ritonavir (ABT-450/r), ombitasvir, and dasabuvir with or without ribavirin has shown efficacy in inducing a sustained virologic response in a phase 2 study involving patients with hepatitis C virus ...
P. Ferenci +28 more
semanticscholar +1 more source
Hepatitis C Virus Epidemic Control Using a Nonlinear Adaptive Strategy [PDF]
arXiv, 2020 Hepatitis C is a viral infection that appears as a result of the Hepatitis C Virus (HCV), and it has been recognized as the main reason for liver diseases. HCV incidence is growing as an important issue in the epidemiology of infectious diseases. In the present study, a mathematical model is employed for simulating the dynamics of HCV outbreak in a ...
arxiv
Hepatitis G Virus Infection in Patients with Hepatitis C
Journal of High Institute of Public Health, 2010 Hepatitis G virus (HGV) infection is a worldwide health problem causing acute and chronic non A- E hepatitis. Because HGV and hepatitis C virus (HCV) share same modes of transmission, co-infection with the two viruses is not uncommon especially among ...
Heba S. Selim +3 more
doaj +1 more source
Altering retinol binding protein 4 levels in hepatitis C: Inflammation and steatosis matter
Virulence, 2020 Both hepatitis C virus (HCV) infection and retinol-binding protein 4 (RBP4) might contribute to insulin resistance (IR), how RBP4 links to IR in HCV infection remain elusive.
Ming-Ling Chang +5 more
doaj +1 more source